Canopy Growth (FRA:11L) FFO


FRA:11L Canopy Growth Corp FRA:11L
59 GF Score
Price €0.84
GF Value €0.61
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Canopy Growth FFO?

FFO (Funds from operations) only applies to REITs.

FRA:11L
59GF Score
Canopy Growth Corp FRA:11L
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Canopy Growth (FRA:11L) Overvalued in 2026?

Based on GuruFocus' analysis, Canopy Growth stock appears to be overvalued. The current stock price of €0.84 is trading 37.1% above its estimated GF Value™ of €0.61. GuruFocus considers Canopy Growth to be Significantly Overvalued.

Key valuation signals for FRA:11L:

  • FFO:
  • GF Value™: €0.61 vs. price of €0.84 (37.1% above fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the FRA:11L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Canopy Growth Business Description

Address 1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
59GF Score

Get the complete analysis for FRA:11L

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.84
Price
€0.61
GF Value